Author:
Balsari Andrea,Caruso Arnaldo
Reference12 articles.
1. Ishizaka S, Tsujii T. IL-2 antibody production in lupus mice. Cell. Immunol 1989; 118: 100-.
2. Whitehead RP, Ward D, Hemingway L, Hemstreet GP, Bradley E, Konrad M. Subcutaneus recombinant interleukin 2 in a dose escalating regimen in patients with metastatic renal cell adenocarcinoma. Cancer Res 1990; 15:6708–6714.
3. Allegretta M, Atkins MB, Dempsey RA, Bradley EC, Konrad MW, Childs A, Wolfe SN, Mier JW. The development of antiInterleukin-2 antibodies in patients treated with recombinant human interleukin-2 (IL-2). J Clin Immunol 1986;6: 481–486.
4. Bost KL, Hahn BH, Saag MS, Shaw GM, Weigent DA, Blalock JE. Individuals infected with HIV possess antibodies against IL-2. Immunology 1988; 65: 611–615.
5. Turano A, Balsari A, Viani E, Landolfo S, Zanoni L, Gargiulo F, Caruso A. Natural human antibodies to γ interferon interfere with the immunomodulating activity of the lymphokine. Proc Natl Acad Sci USA 1992; 89: 4447–4451.